FDA label
What is Nyamyc used for?
Nyamyc contains nystatin. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Nyamyc®(Nystatin Topical Powder, USP) is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicansand other susceptible Candidaspecies.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Nyamyc?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Nyamyc, powder
Indications and Usage, quoted from the label by Upsher-Smith Laboratories, LLC (ANDA065183). Cross-references to other label sections are left out.
Nyamyc®(Nystatin Topical Powder, USP) is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicansand other susceptible Candidaspecies.
Nyamyc® (Nystatin Topical Powder, USP) is not indicated for systemic, oral, intravaginal or ophthalmic use.
Source: DailyMed label, set id 01b44f91-9b68-464a-9693-b5d3e793bf3c, version 12, effective July 9, 2025. NDC 0832-0465, one of 1 listing for this product.
Questions
What is Nyamyc used for?
The FDA label says: “Nyamyc®(Nystatin Topical Powder, USP) is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicansand other susceptible Candidaspecies.”
What drug class is Nyamyc?
FDA lists nystatin in the Polyene Antifungal established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.